RYM.AX · RYMAN HEALTHCARE LIMITED
Australia · RS rating 32 · As of 2026-10-14
| Price | 1.46 AUD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 45 / 30 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 15 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +44.2% |
| Market cap (USD) | $954.2M |